Skip to content

A study to determine the effect of Ayurvedic oil massage therapy (Abhyanga) on stress levels in adults.

Clinical Efficacy of Abhyanga in Stress Management: An Open-Label Single-Arm Study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102537
Enrollment
30
Registered
2026-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Ayurvedic and Unani Tibbia College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Participants belonging to the age group of 18 to 50 years, of either gender. 2.Participants with PSS score less than 27.

Exclusion criteria

Exclusion criteria: 1. Diagnosed psychiatric disorders (as per DSM-5/ICD-10). 2. Individuals currently on medications known to affect stress physiology or cortisol levels (e.g.,corticosteroids, antidepressants, anxiolytics) for a continuous duration of more than 4 weeks prior to enrollment. 3. Participants with PSS score above 26. 4. Patient with uncontrolled diabetes, hypertension, hypothyroidism and severe obesity. 5. Currently pregnant or postpartum state or lactating women. 6. History of substance abuse and dependence or violent behavior. 7. Participants with suicidal ideation or tendency. 8. Conditions where Abhyanga was contraindicated like Acute febrile conditions (Navajwara),Indigestion (Ajeerna) or after heavy meals, Hemorrhagic conditions (Raktapitta), Acute diarrhea (Atisara), Immediately post-Panchakarma procedures and Skin infections, wounds,or inflamed areas. 9. Subject with any allergies to oil.

Design outcomes

Primary

MeasureTime frame
Improvement in perceived stress levels following Abhyanga, measured using PSS-10, VAS for Stress, and WHOQOL-BREF.Timepoint: Day 0: Screening/Baseline Day 1: Assessment Before Procedure Day 2-15: Therapy(Abhyanga) Day 16: Assessment After Procedure After 15 days, follow up will be incorporated.

Secondary

MeasureTime frame
Changes in selective stress biomarkers (e.g., serum cortisol) reflecting physiological response to Abhyanga. Assessment of the safety and tolerability of Abhyanga therapy through monitoring of procedural compliance, participant tolerability, and occurrence of any Adverse Events (AEs) or Adverse Drug Reactions (ADRs) related to the therapy or oil used during the study period. Evaluation of the subjective well-being experienced by participants after Abhyanga therapy.Timepoint: Day 0: Screening/Baseline Day 1: Assessment Before Procedure Day 2-15: Therapy(Abhyanga) Day 16: Assessment After Procedure After 15 days, follow up will be incorporated.

Countries

India

Contacts

Public ContactDr Sujata Rajan

Ayurvedic and Unani Tibbia College and Hospital

sujataa.rajan@gmail.com9818473595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026